Home » Topics » Regulatory

Regulatory
RSS

Tygacil receives FDA approval

June 17, 2005

Enbrel approved to improve physical function in psoriatic arthritis

June 2, 2005

FDA approval for Naglazyme

June 2, 2005

New approval for Arixtra

May 31, 2005

Remicade approved for psoriatic arthritis

May 18, 2005

Requip approved for moderate to severe primary restless legs syndrome

May 6, 2005

Oral-lyn insulin spray approved in Ecuador

May 4, 2005

FDA approval for Byetta

May 3, 2005

Cypher stent approved for MRI scans immediately following implantation

April 22, 2005

Canadian approval for Sativex

April 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...